These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27353044)

  • 1. CXCL16 Deficiency Attenuates Renal Injury and Fibrosis in Salt-Sensitive Hypertension.
    Liang H; Ma Z; Peng H; He L; Hu Z; Wang Y
    Sci Rep; 2016 Jun; 6():28715. PubMed ID: 27353044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of CXCL16 in hypertensive kidney injury and fibrosis.
    Xia Y; Entman ML; Wang Y
    Hypertension; 2013 Dec; 62(6):1129-37. PubMed ID: 24060897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis.
    Ma Z; Jin X; He L; Wang Y
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H815-21. PubMed ID: 27496882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension.
    Wu Y; An C; Jin X; Hu Z; Wang Y
    Sci Rep; 2020 Jan; 10(1):133. PubMed ID: 31924817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    Gao Y; Liu B; Guo X; Nie J; Zou H; Wen S; Yu W; Liang H
    J Hypertens; 2023 May; 41(5):794-810. PubMed ID: 36883469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
    Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
    Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension.
    Gao Y; Yu W; Song J; Nie J; Cui Z; Wen S; Liu B; Liang H
    Hypertens Res; 2023 Aug; 46(8):1934-1948. PubMed ID: 37248323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.
    Jennings BL; Estes AM; Anderson LJ; Fang XR; Yaghini FA; Fan Z; Gonzalez FJ; Campbell WB; Malik KU
    Hypertension; 2012 Dec; 60(6):1510-6. PubMed ID: 23108654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
    Rhaleb NE; Pokharel S; Sharma U; Carretero OA
    J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension.
    Wei X; Gao P; Pu Y; Li Q; Yang T; Zhang H; Xiong S; Cui Y; Li L; Ma X; Liu D; Zhu Z
    Clin Sci (Lond); 2017 Apr; 131(7):567-581. PubMed ID: 28143892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.
    Yao B; Harris RC; Zhang MZ
    Hypertension; 2009 Nov; 54(5):1077-83. PubMed ID: 19770404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL16 regulates cisplatin-induced acute kidney injury.
    Liang H; Zhang Z; He L; Wang Y
    Oncotarget; 2016 May; 7(22):31652-62. PubMed ID: 27191747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice.
    Thomas JM; Ling YH; Huuskes B; Jelinic M; Sharma P; Saini N; Ferens DM; Diep H; Krishnan SM; Kemp-Harper BK; O'Connor PM; Latz E; Arumugam TV; Guzik TJ; Hickey MJ; Mansell A; Sobey CG; Vinh A; Drummond GR
    Hypertension; 2021 Nov; 78(5):1296-1309. PubMed ID: 34488433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B; Wang W; Ji XY; Ritter JK; Li N
    BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.
    Weng HC; Lu XY; Xu YP; Wang YH; Wang D; Feng YL; Chi Z; Yan XQ; Lu CS; Wang HW
    Mol Med; 2021 Nov; 27(1):147. PubMed ID: 34773993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway.
    Chen Z; Wu C; Liu Y; Li H; Zhu Y; Huang C; Lin H; Qiao Q; Huang M; Zhu Q; Wang L
    Cell Death Dis; 2020 Aug; 11(8):698. PubMed ID: 32829380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase γ deficiency attenuates kidney injury and fibrosis in angiotensin II-induced hypertension.
    An C; Wen J; Hu Z; Mitch WE; Wang Y
    Nephrol Dial Transplant; 2020 Sep; 35(9):1491-1500. PubMed ID: 32500132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
    Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
    Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.